User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses
These side effects vary from mild nausea to serious organ injuries and cancer
Bulk drug substances used in compounding under Section 503B of the FD&C Act.
Essentially, it allows your body to break down carbohydrates and fat for fuel and metabolize protein for muscle-building
BuhlT , Thim L, Kofod H, Orskov C, Harling H, Holst JJ
Can I still carb-load the night before a marathon on GLP-1